Join to view full profile
1010 W La Veta Avesuite 200Orange, CA 92868
Phone+1 714-541-6622
Fax+1 714-541-0531
Dr. Byun is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Timothy Byun, MD is a seasoned Oncologist based in Orange, CA. His education includes a Fellowship in Hematology and Medical Oncology and a Residency in Internal Medicine from the University of California, Irvine, as well as a medical degree from Rush Medical College of Rush University Medical Center. Dr. Byun has substantial experience in managing oncology conditions such as GI cancers, skin cancer, hematologic oncology, breast cancer, lung cancer, and prostate cancer. He has contributed to the medical field through various publications in Military Medicine and Oncology. Furthermore, he has conducted clinical trials studying the effectiveness of various treatments for conditions like COVID-19 during the pandemic and multiple cancer conditions including lung, breast, colorectal cancer and melanoma.
Education & Training
University of California (Irvine)Fellowship, Hematology and Medical Oncology, 2001 - 2004- University of California (Irvine)Residency, Internal Medicine, 1998 - 2001
Rush Medical College of Rush University Medical CenterClass of 1998
Certifications & Licensure
CA State Medical License 1999 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2013, 2015-2016
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2013, 2015-2016
Clinical Trials
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
- Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery Start of enrollment: 2011 Jun 17
Publications & Presentations
PubMed
- 14 citationsInhaled Sargramostim (Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor) for COVID-19-Associated Acute Hypoxemia: Results of the Phase 2, Randomized, ...Robert Paine, Robert Chasse, E Scott Halstead, Jay Nfonoyim, David J Park
Military Medicine. 2023-07-22 - 5 citationsManaging colorectal cancer liver metastases.Lawrence D. Wagman, Timothy E. Byun
Oncology. 2009-11-13
Professional Memberships
- Member
- Member
- Member
Other Languages
- Korean
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
